MedTrace Logo

Analyze the Comparison of the Effectiveness of Kinesio ®and Dynamic Taping for De Quervain's Tenosynovitis

NCT07062276 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2025-07-14

No results posted yet for this study

Summary

\_De Quervain's tenosynovitis is inflammation and swelling of the tendon caused by repetitive thumb movements. In severe cases, the tendon sliding is limited, resulting in limited joint range of motion and affecting the quality of life. Kinesio ®can effectively improve pain, edema, and assist functional movements. The elasticity of the patch creates wrinkles to relax the extensor pollicis brevis and the abductor longus muscle of the thumb. The dynamic tape is a new type of treatment. The material has high resilience. Its purpose is to help muscles and tissues absorb external forces and reduce tissue energy consumption. By adjusting the human motor control mode, the work of injured tissues can be reduced, thereby improving the discomfort of sports injuries , accelerating the recovery of injured tissues and reducing the load of the extensor pollicis brevis tendon and the abductor pollicis longus tendon to assist the two tendons in their work. However, in the past, there was no dynamic taping applied to the study of De Quervain's tenosynovitis, and no dynamic taping and Kinesio ® applied to the study of De Quervain's tenosynovitis.

Conditions

  • De Quervain's Tenosynovitis

Interventions

OTHER

Dynamic taping

The dynamic tape is a new type of treatment. The material has high resilience. Its purpose is to help muscles and tissues absorb external forces and reduce tissue energy consumption.

OTHER

Kinesio ®

Kinesio ®can effectively improve pain, edema, and assist functional movements. The elasticity of the patch creates wrinkles to relax the extensor pollicis brevis and the abductor longus muscle of the thumb.

Sponsors & Collaborators

  • Taipei Medical University Shuang Ho Hospital

    lead OTHER

Principal Investigators

  • Hung-Chou Chen · Taipei Medical University, Taiwan, R.O.C.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-30
Primary Completion
2022-12-20
Completion
2022-12-20

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07062276 on ClinicalTrials.gov